Danaher Corp (NYSE:DHR)
$ 240.8 -0.49 (-0.2%) Market Cap: 173.92 Bil Enterprise Value: 189.21 Bil PE Ratio: 45.95 PB Ratio: 3.39 GF Score: 86/100

Danaher Corp at TD Cowen Health Care Conference Transcript

Mar 05, 2024 / 04:10PM GMT
Release Date Price: $254.39 (-0.70%)
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst

Thank you. Dan Brennan from TD Cowan Life Science Tools Diagnostics. And we're here at 44th Annual Global Healthcare Conference. Really pleased to be joined here on the stage Rainer Blair, President and CEO of Danaher Corporation. So Rainer, thank you very much for being here.

Rainer M. Blair
Danaher Corporation - President, CEO & Director

Thanks, Dan. Good to see you.

Questions & Answers

Daniel Gregory Brennan;Rainer M. Blair
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst;Danaher

As a reminder, you took over CEO of Danaher back September 2020, in the middle of COVID, quite a volatile period. You set your steady-state growth rate high single digits back in, I think, the fall of 2022. Maybe just speak to the key drivers of that kind of growth rate, your confidence and then outlook given the continued end market volatility since it was offered?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot